Hologic, Inc. Stock price

Equities

HOLX

US4364401012

Advanced Medical Equipment & Technology

Market Closed - Nasdaq 03:59:59 2023-12-11 pm EST Intraday chart for Hologic, Inc. 5-day change 1st Jan Change
68.71 USD +0.50% -2.65% -8.15%
Sales 2024 * 4B Sales 2025 * 4.22B Capitalization 16.41B
Net income 2024 * 780M Net income 2025 * 842M EV / Sales 2024 *
3,97x
Net cash position 2024 * 542M Net cash position 2025 * 1.6B EV / Sales 2025 *
3,51x
P/E ratio 2024 *
21,2x
P/E ratio 2025 *
19,4x
Employees 6,990
Yield 2024 *
-
Yield 2025 *
-
Free-Float 80.22%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.50%
1 week-2.65%
Current month-3.63%
1 month-3.77%
3 months-5.61%
6 months-12.43%
Current year-8.15%
More quotes
1 week
67.59
Extreme 67.5921
70.42
1 month
67.59
Extreme 67.5921
73.05
Current year
64.02
Extreme 64.02
87.88
1 year
64.02
Extreme 64.02
87.88
3 years
59.78
Extreme 59.78
87.88
5 years
26.49
Extreme 26.49
87.88
10 years
19.91
Extreme 19.91
87.88
More quotes
Managers TitleAgeSince
Chief Executive Officer 59 2013
Director of Finance/CFO 53 2005
Chief Tech/Sci/R&D Officer - 2021
Members of the board TitleAgeSince
Chief Executive Officer 59 2013
Director/Board Member 68 2017
Director/Board Member 62 2016
More insiders
Date Price Change Volume
23-12-11 68.71 +0.50% 1 448 726
23-12-08 68.37 -1.23% 1,672,566
23-12-07 69.22 +0.16% 2,363,544
23-12-06 69.11 -0.22% 1,752,923
23-12-05 69.26 -1.87% 2,062,468

Delayed Quote Nasdaq, December 11, 2023 at 03:59 pm EST

More quotes
Hologic, Inc. is the world leader in the design, manufacturing and marketing of diagnostic products, medical imaging systems and surgical products dedicated to women's health. Net sales break down by area of application as follows: - molecular diagnostics (62.1%): rapid diagnostic tests for human diseases detection (sexually transmitted infections, respiratory diseases, viral diseases, infectious diseases, cancers of the cervix and prostate, etc.) and fetal fibronectin; - breast health (25.3%): digital mammography and breast biopsy solutions and systems; - gynecological surgery (10.8%): endometrial ablation devices, minimally invasive intervention systems for the hysteroscopic elimination of targeted intrauterine diseases (including fibroids and polyps). The group also offers fluid management systems for use in hysteroscopic procedures; - bone health (1.97%): bone imaging systems, bone sonometers and osteodensitometers for bone structure and density, and osteoporotic fractures risk assessment. Net sales break down by source of revenue between sales of products (86.2%) and services (13.8%). Net sales are distributed geographically as follows: the United States (71.3%), Europe (18.3%), Asia/Pacific (7.4%) and other (3%).
More about the company
Trading Rating :
Investor Rating :
ESG Refinitiv :
B+
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
19
Last Close Price
68.37USD
Average target price
79.82USD
Spread / Average Target
+16.75%
Consensus
  1. Stock
  2. Equities
  3. Stock Hologic, Inc. - Nasdaq
Secure and Increase the Performance of your Investments with our Team of Experts at your Side
Securing my Investments
fermer